- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2022 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Weight Management
The Endocrinology Network® Weight Management clinical resource center is the home of all content related to weight loss and obesity management. Now a full-blown epidemic, the obesity crisis is one of the most prominent and dangerous health crises in the US. This page will provide insight and perspective related to FDA approvals, the latest studies, and guideline updates related to nutrition, obesity, and weight management.
More Emphasis on Lifestyle Improvements Needed After Bariatric Surgery, Study Finds
June 29, 2022
An analysis of data from NHANES details trends in lifestyle behaviors, including healthy eating and physical activity, among patients who have undergone bariatric surgery compared to those considered eligible for surgery and those of normal weight.
BYU Study Details Concerning 10-Year Weight Gain Average Among US Adults
June 28, 2022
An analysis of weight gain trends among more than 10,000 US adults suggests nearly 1-in-5 experienced a weight gain of 20% or more during the previous 10 years.
Overweight, Obesity in Adolescence Could Raise Type 1 Diabetes Risk in Adulthood
June 06, 2022
Although typically associated with an increased risk of type 2 diabetes, new research from Israel presented at ADA 2022 suggests increased BMI in adolescence was associated with an increased risk of new-onset type 1 diabetes in young adulthood.
SURMOUNT-1: Tirzepatide Provides Significant, Sustained Weight Loss in Obesity
June 04, 2022
A month and a half after topline results were announced in April, full data from SURMOUNT-1 was presented at ADA 2022 and demonstrate tirzepatide in 5 mg, 10 mg, or 15 mg doses provides superior weight loss compared to placebo therapy, with this weight loss maintained throughout the duration of the trial.
Tirzepatide: A Game-Changer Ready for Primetime?
June 03, 2022
During the opening press conference, Endocrinology Network got perspective from a trio of American Diabetes Association executives on the prospect of tirzepatide as an agent for combatting both diabetes and obesity.
Digital Support Can Help to Optimize Pediatric Obesity Treatments
May 31, 2022
Data from a 1-year pragmatic trial examining use of a mobile health support system outlines the potential impact of using the system on weight loss and treatment effects among patients with pediatric obesity.
Body Composition, Obesity Increase Odds of Developing PCOS
May 24, 2022
Data presented at the European Congress of Endocrinology detail genetic and observational associations between obesity, and markers of body composition on the likelihood of developing PCOS later in life.
Food Insecurity in Young Adulthood Linked to Obesity, Diabetes Risk Later in Life
May 11, 2022
An analysis of data from more than 3500 individuals followed for more than 20 years provides insight into the impact of food insecurity on risk of cardiometabolic conditions, including obesity and type 2 diabetes.
Vegan Diets Can Improve HbA1c, Body Weight in Overweight or Type 2 Diabetes
May 06, 2022
Data from a study presented at the European Congress on Obesity details the effects of adherence to a vegan diet on cardiometabolic health using data obtained from randomized controlled trials assessing the effects of vegan diets as an intervention.
Reducing Sedentary Time By An Hour Per Day Can Provide Health Benefits in Metabolic Syndrome
May 05, 2022
A 3-month trial found reducing sedentary time by just an hour per day was enough to produce statistically significant changes in biomarkers for cardiovascular risk among patients with metabolic syndrome.